Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 13;2(2):CD016019.
doi: 10.1002/14651858.CD016019.

Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedema

Yvonne Haas  1   2 , Olivia P Williams  2 , Jaume Masia  3 , Gemma Pons  3 , Erin M Taylor  4 , Maria C Katapodi  5   6 , Daniel Staub  7 , Steffen U Eisenhardt  8 , Giuseppe Visconti  9 , Benedetto Longo  10 , Jan Plock  11 , Florian Jung  12 , Eduardo Gonzalez  13 , Benedict Kaiser  1 , Lea Zehnpfennig  14 , Julia Stoffel  1   2 , Florian S Halbeisen  15 , Christian Appenzeller-Herzog  16 , Laura Hilbig-Vlatten  17 , Yvette Stoel  18 , Raymund E Horch  19 , Maria Mani  20 , Karin Ribi  21 , Joshua Vorstenbosch  22 , Kathryn V Isaac  23 , Shan Shan Qiu  24 , Björn Behr  25 , Lars G Hemkens  5   26   27 , Nicole Lindenblatt  28 , Dirk J Schaefer  1   2 , Katrin Seidenstuecker  29 , Yves Harder  30   31 , Christoph R Hirche  32 , Walter P Weber  2   33 , Elisabeth A Kappos  1   2
Affiliations

Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedema

Yvonne Haas et al. Cochrane Database Syst Rev. .

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of microsurgery versus complex physical decongestive therapy in people with chronic breast cancer-related lymphoedema.

PubMed Disclaimer

Conflict of interest statement

YHaa, OPW, JM, GP, EMT, MK, DS, GV, BL, FJ, EG, BK, LZ, JS, FSH, CA‐H, LH‐V, YS, REH, KR, JV, KVI, SSQ, LGH, DJS, KS, EAK: no conflict of interest.

MM: Elected representative at lymphoedema national evaluation group for lymphoedema care in Sweden, Microsure (scientific board member; development of robot for microsurgery), breast cancer association for research on lymphoedema (grant).

BB: Consultant for Julius Zorn GmbH.

SE: Deutsche Forschungsgemeinschaft (grant/contract).

YHar: Clinical consultant for device development, author Modern Surgical Management of Chronic Lymphedema (Thieme; ISBN: 9783132414280).

CRH: Advisory Board at 3M Company.

NL: Consultant and scientific advisor for Medical Microinstruments (MMI).

JP: Medical and Marketing Consultant for Kerecis Limited, Scientific Advisor and Speaker for Nanomedic.

WW: Speaking engagement for MSD.

References

Additional references

Bakbergenuly 2018
    1. Bakbergenuly I, Kulinskaya E. Meta-analysis of binary outcomes via generalized linear mixed models: a simulation study. BMC Medical Research Methodology 2018;18(1):70. [DOI: 10.1186/s12874-018-0531-9] - DOI - PMC - PubMed
Becker 2006
    1. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Annals of Surgery 2006;243(3):9313-5. [DOI: 10.1097/01.sla.0000201258.10304.16] - DOI - PMC - PubMed
Borenstein 2013
    1. Borenstein M, Higgins JP. Meta-analysis and subgroups [Meta-analysis and subgroups]. Prevention Science 2013;14(2):134-43. [DOI: 10.1007/s11121-013-0377-7] - DOI - PubMed
Borissov 2022
    1. Borissov N, Haas Q, Minder B, Kopp-Heim D, Gernler M, Janka H et al. Reducing systematic review burden using Deduklick: a novel, automated, reliable, and explainable deduplication algorithm to foster medical research. Systematic Reviews 2022;11(1):172. [DOI: 10.1186/s13643-022-02045-9] - DOI - PMC - PubMed
Boyages 2016
    1. Boyages J, Kalfa S, Xu Y, Koelmeyer L, Mackie H, Viveros H et al. Worse and worse off: the impact of lymphedema on work and career after breast cancer. Springer Plus 5 2016;657:657. [DOI: 10.1186/s40064-016-2300-8] - DOI - PMC - PubMed
Bramer 2018
    1. Bramer WM, Rethlefsen ML, Mast F, Kleijnen J. Evaluation of a new method for librarian-mediated literature searches for systematic reviews. Research Synthesis Methods 2018;9(4):510-20. [DOI: 10.1002/jrsm.1279] - DOI - PMC - PubMed
Byun 2021
    1. Byun HK, Chang JS, Im SH, Kirova YM, Arsene-Henry A, Choi SH et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective. Annals of Surgery 2021;274(1):170-8. [DOI: 10.1097/SLA.0000000000003491] - DOI - PubMed
Campbell 2020
    1. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2016;368:16890. [DOI: 10.1136/bmj.l6890] - DOI - PMC - PubMed
Chachaj 2009
    1. Chachaj A, Małyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudełko M et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psycho-Oncology 2009;19(3):299-305. [DOI: 10.1002/pon.1573] - DOI - PubMed
Cidón 2011
    1. Cidón EU, Perea C, López-Lara F. Life after breast cancer: dealing with lymphoedema. Clinical Medicine Insights 2011;Oncology(5):9–14. [DOI: 10.4137/CMO.S6389] - DOI - PMC - PubMed
Clark 2020
    1. Clark JM, Sanders S, Carter M, Honeyman D, Cleo G, Auld Y, et al. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. Journal of the Medical Library Association 2020;108(2):195-207. [DOI: 10.5195/jmla.2020.834] [PMID: ] - DOI - PMC - PubMed
Cohen 1988
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale (NJ): Lawrence Erlbaum Associates Inc, 1988.
Coriddi 2020
    1. Coriddi M, Dayan J, Sobti N, Nash D, Goldberg J, Klassen A et al. Systematic review of patient-reported outcomes following surgical treatment of lymphedema. Cancers 2020;12(3):565. [DOI: 10.3390/cancers12030565] - DOI - PMC - PubMed
Covidence 2024 [Computer program]
    1. Covidence. Version accessed 12 June 2024. Melbourne: Veritas Health Innovation, 2024. Available from https://www.covidence.org/.
Deeks 2023
    1. Deeks JJ, Higgins JPT, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook/archive/v6.4.
DeepL 2017 [Computer program]
    1. DeepL Translate: The world's most accurate translator. DeepL.. DeepL Translator. DeepL, 2017. Available from https://www.deepl.com.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88. [DOI: 10.1016/0197-2456(86)90046-2] [PMID: ] - DOI - PubMed
Devoogdt 2011
    1. Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens MR. Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): Reliability and validity. Physical Therapy 2011;91:944-57. [DOI: 10.2522/ptj.20100087] - DOI - PubMed
Dionyssiou 2016
    1. Dionyssiou D, Demiri E, Tsimponis A, Sarafis A, Mpalaris V, Tatsidou G et al. A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer. Breast Cancer Research and Treatment 2016;156(1):73-9. [DOI: 10.1007/s10549-016-3716-0] - DOI - PubMed
DiSipio 2013
    1. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. The Lancet Oncology 2013;14(6):500-15. [DOI: 10.1016/S1470-2045(13)70076-7] - DOI - PubMed
Doubblestein 2024
    1. Doubblestein D, Koehler L, Anderson E, Scheiman N, Stewart P, Schaverien M, et al. Development of a core outcome set for breast cancer-related lymphedema: a Delphi study [Development of a core outcome set for breast cancer-related lymphedema: a Delphi study]. Breast Cancer Research and Treatment 2024;205:359-70. [DOI: 10.1007/s10549-024-07262-5] - DOI - PMC - PubMed
Egger 1997
    1. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. - PMC - PubMed
Eldridge 2021
    1. Eldridge S, Campbell MK, Campbell MJ, Drahota AK, Giraudeau B, Reeves BC, et al. Revised Cochrane risk of bias tool for randomized trials (RoB 2). Additional considerations for cluster-randomized trials (RoB 2 CRT). https://www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-cluster-rando....
EndNote 2021 [Computer program]
    1. EndNote. Version EndNote 20. Philadelphia (PA): Clarivate Analytics, 2021. Available at https://endnote.com.
Engel 2003
    1. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Research and Treatment 2003;79:47–57. [DOI: ] - PubMed
Fergusson 2002
    1. Fergusson D, Aaron SD, Guyatt G, Hébert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325(7365):652-4. [DOI: 10.1136/bmj.325.7365.652] - DOI - PMC - PubMed
Flores 2021
    1. Flores T, Bergmeister KD, Staudenherz A, Pieber K, Schrögendorfer KF. Diagnosis, prevention and therapy of lymphedema [Diagnostik, Prävention und Therapie des Lymphödems]. Wiener klinische Wochenschrift 2021;133(15-16):855–68. [DOI: 10.1007/s00508-020-01766-y] - DOI - PMC - PubMed
Forte 2020
    1. Forte AJ, Khan N, Huayllani MT, Boczar D, Saleem HY, Lu X, et al. Lymphaticovenous anastomosis for lower extremity lymphedema: a systematic review. Indian Journal of Plastic Surgery 2020;53(1):17-24. [DOI: 10.1055/s-0040-1709372] - DOI - PMC - PubMed
Fu 2013
    1. Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psycho-Oncology 2013;22:1466-84. [DOI: 10.1002/pon.3201] - DOI - PMC - PubMed
Fu 2014
    1. Fu MR. Breast cancer-related lymphedema: symptoms, diagnosis, risk reduction, and management. World Journal of Clinical Oncology 2014;10(5):241-7. [DOI: 10.5306/wjco.v5.i3.241] [PMID: ] - DOI - PMC - PubMed
Grada 2017
    1. Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. Journal of the American Academy of Dermatology 2017;77(6):1009-20. [DOI: 10.1016/j.jaad.2017.03.022] - DOI - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version accessed 31 May 2024. Hamilton (ON): McMaster University (developed by Evidence Prime), 2024. Available from gradepro.org.
Greene 2016
    1. Greene AK, Maclellan RA. Operative treatment of lymphedema using suction-assisted lipectomy. Annals of Plastic Surgery 2016;77(3):337-40. [DOI: 10.1097/SAP.0000000000000597] - DOI - PubMed
Gärtner 2010
    1. Gärtner R, Jensen M, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment--a nationwide study of prevalence and associated factors. Breast 2010;19(6):506-15. [DOI: 10.1016/j.breast.2010.05.015] - DOI - PubMed
Hayes 1921
    1. Hayes MHS, Patterson DG. Experimental development of the graphic rating method. Psychological Bulletin 1921;18:98–9.
Heinig 2015
    1. Heinig B, Wollina U. Complex decongestive therapy [Komplexe physikalische Entstauungstherapie]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2015;66(11):810-8. [DOI: 10.1007/s00105-015-3674-1] - DOI - PubMed
Higgins 2019
    1. Higgins JPT, Savović J, Page MJ, Sterne JAC. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2.
Higgins 2024
    1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. Available from www.training.cochrane.org/handbook.
Hirche 2019
    1. Hirche C, Engel H, Seidenstuecker K, Taeger C, Machens H-G, Frick A, et al. Lympho-reconstructive microsurgery for secondary lymphedema: Consensus of the German-Speaking Society for Microsurgery of Peripheral Nerves and Vessels (DAM) on indication, diagnostic and therapy by lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) [Rekonstruktive Mikrochirurgie des sekundären Lymphödems: Konsensus der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der peripheren Nerven und Gefässe (DAM) zur Indikation, Diagnostik und Therapie mittels Lymphovenöser Anastomosen (LVA) und vaskularisierter Lymphknotentransplantation (VLKT)]. Handchirurgie, Mikrochirurgie, plastische Chirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft für Handchirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der Peripheren Nerven und Gefässe: Organ der Vereinigung der Deutschen Plastischen Chirurgen 2019;51(6):424–33. [DOI: 10.1055/a-0874-2212] - DOI - PubMed
Hong 2018
    1. Hong JP, Song S, Suh HSPJ. Supermicrosurgery: Principles and applications. Journal of Surgical Oncology 2018;118:832-9. [DOI: 10.1002/jso.25243] - DOI - PubMed
International Society of Lymphology 2013
    1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46(1):1-11. [PMID: ] - PubMed
International Society of Lymphology 2020
    1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus document of the International Society of Lymphology. Lymphology 2020;53(1):3-19. [DOI: 10.2458/lymph.4649] - DOI - PubMed
Jeffs 2018
    1. Jeffs E, Ream E, Taylor C, Bick D. Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review. BI Database of Systematic Reviews and Implementation Reports 2018;16(2):453-506. [DOI: 10.11124/JBISRIR-2016-003185] - DOI - PMC - PubMed
Jorgensen 2018
    1. Jorgensen MG, Toyserkani NM, Sorensen JA. The effect of prophylactic lymphovenous anastomosis and shunts for preventing cancer-related lymphedema: a systematic review and meta-analysis. Microsurgery 2018;38(5):576-85. [DOI: 10.1007/s10549-017-4335-0] - DOI - PubMed
Keeley 2010
    1. Keeley V, Crooks S, Locke J, Veigas D, Riches K and Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). Journal of Lymphoedema 2010;5:26-37. [AVAILABLE FROM: https://oro.open.ac.uk/32567/]
Khan 2012
    1. Khan F, Amatya B, Pallant JF, Rajapaksa I. Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast 2012;21(3):314-20. [DOI: 10.1016/j.breast.2012.01.013] - DOI - PubMed
Kilbreath 2016
    1. Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast 2016;28:29-36. [DOI: 10.1016/j.breast.2016.04.011] [PMID: ] - DOI - PubMed
Klassen 2021
    1. Klassen AF, Tsangaris E, Kaur MN, Poulsen L, Beelen LM, Lind Jacobsen A, et al. Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: The LYMPH-Q Upper Extremity Module. Annals of Surgical Oncology 2021;28:5166-82. [DOI: 10.1245/s10434-021-09887-y] - DOI - PMC - PubMed
Langer 2007
    1. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Annals of Surgery 2007;245(3):452-61. [DOI: 10.1097/01.sla.0000245472.47748.ec] [PMID: ] - DOI - PMC - PubMed
Launois 2002
    1. Launois R, Mègnigbêto AC, Pocquet K, Alliot F. A specific quality of life scale in upper limb lymphedema: the ULL‐27 questionnaire. Lymphology 2002;35:181-7. [AVAILABLE FROM: https://www.researchgate.net/profile/Robert-Launois/publication/25165851...]
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1–34. [DOI: 10.1016/j.jclinepi.2009.06.006] - DOI - PubMed
Markkula 2019
    1. Markkula SP, Leung N, Allen VB, Furniss D. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No: CD011433. [DOI: 10.1002/14651858.CD011433.pub2] - DOI - PMC - PubMed
McGuinness 2020
    1. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods 2021;12(1):55-61. [DOI: 10.1002/jrsm.1411] - DOI - PubMed
McKenzie 2019
    1. McKenzie JE, Brennan SE. Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from training.cochrane.org/handbook/archive/v6.
McLaughlin 2008
    1. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. Journal of Clinical Oncology 2008;26(32):5213-9. [DOI: 10.1200/JCO.2008.16.3725] - DOI - PMC - PubMed
Mortimer  1998
    1. Mortimer PS. The pathophysiology of lymphedema. Cancer 1998 ;83(12 Suppl):2798-802. [DOI: 10.1002/(sici)1097-0142(19981215)83:12b+<2798::aid-cncr28>3.3.co;2-5] [PMID: ] - DOI - PubMed
National Cancer Institute 2023
    1. National Cancer Institute. NCI Dictionaries. www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-disease.
NICE guidance 2022
    1. National Institute for Health and Care Excellence (NICE). Liposuction for chronic lymphoedema - the condition, current treatments and procedure. NICE guidance - Interventional procedures guidance [IPG723]. www.nice.org.uk/guidance/ipg723.
Ozturk 2016
    1. Ozturk CN, Ozturk C, Glasgow M, Platek M, Ashary Z, Kuhn J, et al. Free vascularized lymph node transfer for treatment of lymphedema: A systematic evidence based review. Journal of Plastic, Reconstructive & Aesthetic Surgery 2016;69(9):1234-47. [DOI: 10.1016/j.bjps.2016.06.022] - DOI - PubMed
Page 2021
    1. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372(n71):1-9. [DOI: 10.1136/bmj.n71] - DOI - PMC - PubMed
Park 2020
    1. Park KE, Allam O, Chandler L, Mozzafari MA, Ly C, Lu X, et al. Surgical management of lymphedema: a review of current literature. Gland Surgery 2020;9(2):503-11. [DOI: 10.21037/gs.2020.03.14] - DOI - PMC - PubMed
Qiu 2020
    1. Qiu SS, Pruimboom T, Cornelissen AJM, Schols RM, Kuijk SMJ, Hulst RRWJ. Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up. Breast Cancer Research and Treatment 2020;184(1):173-83. [DOI: 10.1007/s10549-020-05839-4] [PMID: ] - DOI - PMC - PubMed
Reeves 2017
    1. Reeves BC, Wells GA, Waddington H. Quasi-experimental study designs series-paper 5: a checklist for classifying studies evaluating the effects on health interventions-a taxonomy without labels. Journal of Clinical Epidemiology 2017;89:30-42. [DOI: 10.1016/j.jclinepi.2017.02.016] - DOI - PMC - PubMed
Reeves 2024
    1. Reeves BC, Deeks JJ, Higgins JPT, Shea B, Tugwell P, Wells GA. Chapter 24: Including non-randomized studies on intervention effects [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. Available from www.training.cochrane.org/handbook.
RevMan 2024 [Computer program]
    1. Review Manager (RevMan). Version 7.12.0. The Cochrane Collaboration, 2024. Available at https://revman.cochrane.org.
Ridner 2005
    1. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Supportive Care in Cancer 2005;13(11):904-11. [DOI: 10.1007/s00520-005-0810-y] - DOI - PubMed
Ridner 2013
    1. Ridner SH. Pathophysiology of lymphedema. Seminars in Oncology Nursing 2013;29(1):4-11. [DOI: 10.1016/j.soncn.2012.11.002] [PMID: ] - DOI - PubMed
Rojas 2016
    1. Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clinical Obstetrics and Gynecology 2016;59(4):651-72. [DOI: 10.1097/GRF.0000000000000239] [PMID: ] - DOI - PubMed
Rosian 2019
    1. Rosian K, Stanak M. Efficacy and safety assessment of lymphovenous anastomosis in patients with primary and secondary lymphoedema: a systematic review of prospective evidence. Microsurgery 2019;39(8):763-72. [DOI: 10.1002/micr.30514] - DOI - PMC - PubMed
Sayegh 2017
    1. Sayegh HE, Asdourian MS, Swaroop MN, Brunelle CL, Skolny MN, Salama L, et al. Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions. Current Breast Cancer Reports 2017;9(2):111-21. [DOI: 10.1007/s12609-017-0237-8] - DOI - PMC - PubMed
Scaglioni 2017
    1. Scaglioni MF, Fontein DBY, Arvanitakis M, Giovanoli P. Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedema. Microsurgery 2017;37(8):947-53. [DOI: 10.1002/micr.30246] - DOI - PubMed
Schünemann 2023
    1. Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook/archive/v6.4.
Shah 2011
    1. Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. International Journal of Radiation Oncology, Biology & Physics 2011;81(4):907-14. [DOI: 10.1016/j.ijrobp.2011.05.043] - DOI - PubMed
Shaitelman 2017
    1. Shaitelman SF, Chiang YJ, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Research and Treatment 2017;162(2):201-15. [DOI: 10.1007/s10549-016-4089-0] - DOI - PubMed
Smoot  2010
    1. Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N, Dodd M. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. Journal of Cancer Survivorship: Research and Practice 2010;4(2):167-78. [DOI: 10.1007/s11764-010-0118-x] - DOI - PMC - PubMed
Sterne 2016
    1. Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ 2016;355:4919. - PMC - PubMed
Tourani 2016
    1. Tourani SS, Taylor GI, Ashton MW. Long-term patency of lymphovenous anastomoses: a systematic review. Plastic and Reconstructive Surgery 2016;138(2):492-8. [DOI: 10.1097/PRS.0000000000002395] - DOI - PubMed
Tsai 2009
    1. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Annals of Surgical Oncology 2009;16(7):1959-72. [DOI: 10.1245/s10434-009-0452-2] - DOI - PubMed
Vassard 2010
    1. Vassard D, Olsen MH, Zinckernagel L, Vibe-Petersen J, Dalton SO, Johansen C. Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study. European Journal of Cancer 2010;46(18):3211-8. [DOI: 10.1016/j.ejca.2010.07.041] - DOI - PubMed
Vignes 2020
    1. Vignes S, Fau-Prudhomot P, Simon L, Sanchez-Bréchot ML, Arrault M, Locher F. Impact of breast cancer-related lymphedema on working women. Support Care Cancer 2020;28(1):79-85. [DOI: 10.1007/s00520-019-04804-2] - DOI - PubMed
Winters 2017
    1. Winters H, Tielemans HJP, Hameeteman M, Paulus VAA, Beurskens CH, Slater NJ et al. The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema. Breast Cancer Research and Treatment 2017;165(2):321–7. [DOI: 10.1007/s10549-017-4335-0] - DOI - PMC - PubMed
Wolfs 2020
    1. Wolfs J, Beugels J, Kimman M, Piatkowski de Grzymala AA, Heuts E, Keuter X et al. Improving the quality of life of patients with breast cancer-related lymphoedema by lymphaticovenous anastomosis (LVA): study protocol of a multicentre randomised controlled trial. BMJ Open 2020;10(1):1-7. [DOI: 10.1136/bmjopen-2019-035337] - DOI - PMC - PubMed

Publication types

LinkOut - more resources